Meltzer, Paul S.
National Cancer Institute (NCI),
United States
2025 Rank: 11001
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 481 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11001 | 11909 |
| Total Cites | 52980 | 58556 |
| H-index | 108 | 114 |
| Hm-index | 31 | 33 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 440 | 443 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1103 | 1140 |
| Number of Single+First+Last Authored Papers | 97 | 97 |
| Total Cites to Single+First+Last Authored Papers | 13672 | 14421 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 46346 | 50009 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
9.52%
|
|
Meltzer, Paul S.
National Institutes of Health (NIH),
United States
2024 Rank: 10692
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 476 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10692 | 11787 |
| Total Cites | 50189 | 55617 |
| H-index | 107 | 113 |
| Hm-index | 31 | 33 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 431 | 434 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 949 | 986 |
| Number of Single+First+Last Authored Papers | 97 | 97 |
| Total Cites to Single+First+Last Authored Papers | 12889 | 13651 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 43812 | 47373 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.17 |
| Self-Citation Percentage |
9.76%
|
|
Meltzer, Paul S.
National Cancer Institute (NCI),
United States
2022 Rank: 10385
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 474 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10385 | 11399 |
| Total Cites | 44341 | 49382 |
| H-index | 100 | 107 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 400 | 403 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 761 | 797 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 11380 | 12120 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 38443 | 41721 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
10.21%
|
|
Meltzer, Paul S.
National Cancer Institute (NCI),
United States
2021 Rank: 10191
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 468 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10191 | 11085 |
| Total Cites | 42668 | 47533 |
| H-index | 98 | 105 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 391 | 393 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 749 | 783 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 11014 | 11737 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 36925 | 40092 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
10.23%
|
|